14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.500 $0.720 Wednesday, 24th Apr 2024 ADXS stock ended at $0.540. During the day the stock fluctuated 0% from a day low at $0.540 to a day high of $0.540.
90 days $0.500 $1.49
52 weeks $0.500 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
Apr 30, 2021 $0.490 $0.519 $0.475 $0.489 7 185 662
Apr 29, 2021 $0.519 $0.539 $0.484 $0.493 6 551 861
Apr 28, 2021 $0.510 $0.518 $0.503 $0.513 4 294 970
Apr 27, 2021 $0.520 $0.545 $0.504 $0.513 8 626 575
Apr 26, 2021 $0.510 $0.524 $0.486 $0.513 12 573 499
Apr 23, 2021 $0.491 $0.499 $0.474 $0.484 4 927 809
Apr 22, 2021 $0.480 $0.508 $0.472 $0.478 7 254 682
Apr 21, 2021 $0.459 $0.485 $0.441 $0.472 6 420 492
Apr 20, 2021 $0.459 $0.471 $0.440 $0.444 6 353 559
Apr 19, 2021 $0.479 $0.489 $0.453 $0.462 6 996 355
Apr 16, 2021 $0.494 $0.500 $0.462 $0.469 9 030 317
Apr 15, 2021 $0.573 $0.580 $0.518 $0.519 6 076 750
Apr 14, 2021 $0.575 $0.595 $0.555 $0.567 6 204 954
Apr 13, 2021 $0.599 $0.600 $0.560 $0.570 3 938 147
Apr 12, 2021 $0.650 $0.655 $0.586 $0.587 8 348 436
Apr 09, 2021 $0.708 $0.719 $0.660 $0.666 5 171 021
Apr 08, 2021 $0.709 $0.733 $0.682 $0.705 3 039 936
Apr 07, 2021 $0.733 $0.734 $0.700 $0.703 2 181 426
Apr 06, 2021 $0.760 $0.760 $0.712 $0.745 2 394 296
Apr 05, 2021 $0.773 $0.790 $0.725 $0.736 4 312 881
Apr 01, 2021 $0.751 $0.798 $0.751 $0.785 2 393 825
Mar 31, 2021 $0.730 $0.760 $0.720 $0.736 1 886 616
Mar 30, 2021 $0.733 $0.740 $0.695 $0.726 2 396 985
Mar 29, 2021 $0.770 $0.797 $0.724 $0.740 2 035 893
Mar 26, 2021 $0.778 $0.83 $0.743 $0.780 3 358 129
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT